Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the Objective Response Rate of KOS-1584, as a
single agent in patients with stage IIIB/IV NSCLC whose disease has progressed following
initial chemotherapy.